ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 671095 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 671095; 2) Community: the network communities that were significantly associated with the response to NSC 671095; 3) Molecule: the relationships between components within communities and NSC 671095; 4) MDR: the compounds that were significantly associated with the NSC 671095.

NSC Compound Enrichment Correlation
NSC 722867 Null 0.0430505868034761 0.025134326
NSC 726267 Null 0.0430505868034761 -0.19257308
NSC 727087 16-[4-(2-diethylaminoethoxy)3-methoxy benzylidene]-17-oxo-5-androsten-3a-yl acetate 0.0430505868034761 0.25746246
NSC 733504 Everolimus 0.0430505868034761 0.01347971
NSC 736802 Null 0.0430505868034761 0.21108472
NSC 758881 Orlistat (USAN) 0.0430505868034761 -0.010760049
NSC 84074 Phosphonium, (3-bromopropyl)triphenyl- bromide 0.0430505868034761 0.2613221
NSC 117274 Null 0.0430505868034764 0.31076206
NSC 15309 2,5-Cyclohexadiene-1,4-dione, 2,5-dimethyl- (9CI) 0.0430505868034764 0.056645944
NSC 269721 Androstan-3-one, 17-[[[(2-chloroethyl)nitrosoamino]carbonyl]oxy]-, (5.alpha.,17.beta.)- 0.0430505868034764 0.085269324
Total:66  Current:57    [First] [Prev] [Next] [Last]